BNP Paribas Downgrades Cemex SAB de CV to Underperform (CX)
CX has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Cemex SAB de CV in a research note on Friday, June 27th. They now have a $15.50 price target on the stock, up previously from $14.00. Analysts at Jefferies Group reiterated a “hold” rating on shares of Cemex SAB de CV in a research note on Thursday, June 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. Cemex SAB de CV currently has a consensus rating of “Buy” and a consensus target price of $15.17.
Cemex SAB de CV (NYSE:CX) opened at 13.23 on Tuesday. Cemex SAB de CV has a 1-year low of $9.4327 and a 1-year high of $13.8173. The stock has a 50-day moving average of $12.88 and a 200-day moving average of $12.73. The company’s market cap is $16.594 billion.
Cemex SAB de CV (NYSE:CX) last released its earnings data on Friday, July 18th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.05. The company had revenue of $4.20 billion for the quarter, compared to the consensus estimate of $4.29 billion. On average, analysts predict that Cemex SAB de CV will post $-0.13 earnings per share for the current fiscal year.
CEMEX SAB de CV (NYSE:CX) is a Mexico-based company principally engaged, through its subsidiaries, in the cement manufacturing.
Receive News & Ratings for Cemex SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cemex SAB de CV and related companies with Analyst Ratings Network's FREE daily email newsletter.